Breakthrough business models : drug development for rare and neglected diseases and individualized therapies: workshop summary, [edited by] Theresa Wizeman, Sally Robinson, and Robert Giffin ; Forum on Drug Discovery, Development, and Translation, Board on Health Services Policy, Institute of Medicine of the National Academies
The Resource Breakthrough business models : drug development for rare and neglected diseases and individualized therapies: workshop summary, [edited by] Theresa Wizeman, Sally Robinson, and Robert Giffin ; Forum on Drug Discovery, Development, and Translation, Board on Health Services Policy, Institute of Medicine of the National Academies
Breakthrough business models : drug development for rare and neglected diseases and individualized therapies: workshop summary, [edited by] Theresa Wizeman, Sally Robinson, and Robert Giffin ; Forum on Drug Discovery, Development, and Translation, Board on Health Services Policy, Institute of Medicine of the National Academies
Resource Information
The item Breakthrough business models : drug development for rare and neglected diseases and individualized therapies: workshop summary, [edited by] Theresa Wizeman, Sally Robinson, and Robert Giffin ; Forum on Drug Discovery, Development, and Translation, Board on Health Services Policy, Institute of Medicine of the National Academies represents a specific, individual, material embodiment of a distinct intellectual or artistic creation found in Missouri University of Science & Technology Library.This item is available to borrow from all library branches.
Resource Information
The item Breakthrough business models : drug development for rare and neglected diseases and individualized therapies: workshop summary, [edited by] Theresa Wizeman, Sally Robinson, and Robert Giffin ; Forum on Drug Discovery, Development, and Translation, Board on Health Services Policy, Institute of Medicine of the National Academies represents a specific, individual, material embodiment of a distinct intellectual or artistic creation found in Missouri University of Science & Technology Library.
This item is available to borrow from all library branches.
- Summary
- "The Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop on June 23, 2008, titled "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies." The purpose of the workshop was to explore innovative strategies for orphan drug development."
- Language
- eng
- Extent
- 1 online resource (xviii, 132 pages)
- Contents
-
- Introduction and overview
- Current model for financing drug development: from concept through approval
- The Food and Drug Administration's Orphan Drug Program
- Diverse funding models
- Strategies for facilitating sharing of research materials and data
- Strategies of navigation intellectual property
- Strategies for facilitating clinical trials
- Summary
- Isbn
- 9786612083556
- Label
- Breakthrough business models : drug development for rare and neglected diseases and individualized therapies: workshop summary
- Title
- Breakthrough business models
- Title remainder
- drug development for rare and neglected diseases and individualized therapies: workshop summary
- Statement of responsibility
- [edited by] Theresa Wizeman, Sally Robinson, and Robert Giffin ; Forum on Drug Discovery, Development, and Translation, Board on Health Services Policy, Institute of Medicine of the National Academies
- Title variation
- Drug development for rare and neglected diseases and individualized therapies
- Subject
-
- United States
- Drugs -- Design
- Drugs -- United States -- Design
- Electronic book
- Electronic books
- MEDICAL -- Allied Health Services | General
- Models, Economic
- Orphan Drug Production -- economics
- Orphan Drug Production -- trends
- Orphan drugs -- Government policy
- Orphan drugs -- Government policy -- United States
- Pharmaceutical policy
- Pharmaceutical policy -- United States
- Research -- economics
- Research -- trends
- United States
- Language
- eng
- Summary
- "The Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop on June 23, 2008, titled "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies." The purpose of the workshop was to explore innovative strategies for orphan drug development."
- Cataloging source
- MMU
- Dewey number
- 362.17/820973
- Illustrations
- illustrations
- Index
- no index present
- Language note
- English
- LC call number
- RA401.A3
- LC item number
- B74 2009eb
- Literary form
- non fiction
- Nature of contents
-
- dictionaries
- bibliography
- NLM call number
-
- 2009 G-098
- QV 736
- NLM item number
- W835b 2009
- http://library.link/vocab/relatedWorkOrContributorName
-
- Wizemann, Theresa M
- Robinson, Sally
- Giffin, Robert B
- Institute of Medicine (U.S.)
- http://library.link/vocab/subjectName
-
- Orphan drugs
- Pharmaceutical policy
- Drugs
- Orphan Drug Production
- Orphan Drug Production
- Models, Economic
- Research
- Research
- United States
- MEDICAL
- Drugs
- Orphan drugs
- Pharmaceutical policy
- United States
- Label
- Breakthrough business models : drug development for rare and neglected diseases and individualized therapies: workshop summary, [edited by] Theresa Wizeman, Sally Robinson, and Robert Giffin ; Forum on Drug Discovery, Development, and Translation, Board on Health Services Policy, Institute of Medicine of the National Academies
- Antecedent source
- unknown
- Bibliography note
- Includes bibliographical references
- Carrier category
- online resource
- Carrier category code
-
- cr
- Carrier MARC source
- rdacarrier
- Color
- mixed
- Content category
- text
- Content type code
-
- txt
- Content type MARC source
- rdacontent
- Contents
- Introduction and overview -- Current model for financing drug development: from concept through approval -- The Food and Drug Administration's Orphan Drug Program -- Diverse funding models -- Strategies for facilitating sharing of research materials and data -- Strategies of navigation intellectual property -- Strategies for facilitating clinical trials -- Summary
- Control code
- 311565225
- Dimensions
- unknown
- Extent
- 1 online resource (xviii, 132 pages)
- File format
- unknown
- Form of item
- online
- Isbn
- 9786612083556
- Level of compression
- unknown
- Media category
- computer
- Media MARC source
- rdamedia
- Media type code
-
- c
- Quality assurance targets
- unknown
- Reformatting quality
- unknown
- Sound
- unknown sound
- Specific material designation
- remote
- System control number
- (OCoLC)311565225
- Label
- Breakthrough business models : drug development for rare and neglected diseases and individualized therapies: workshop summary, [edited by] Theresa Wizeman, Sally Robinson, and Robert Giffin ; Forum on Drug Discovery, Development, and Translation, Board on Health Services Policy, Institute of Medicine of the National Academies
- Antecedent source
- unknown
- Bibliography note
- Includes bibliographical references
- Carrier category
- online resource
- Carrier category code
-
- cr
- Carrier MARC source
- rdacarrier
- Color
- mixed
- Content category
- text
- Content type code
-
- txt
- Content type MARC source
- rdacontent
- Contents
- Introduction and overview -- Current model for financing drug development: from concept through approval -- The Food and Drug Administration's Orphan Drug Program -- Diverse funding models -- Strategies for facilitating sharing of research materials and data -- Strategies of navigation intellectual property -- Strategies for facilitating clinical trials -- Summary
- Control code
- 311565225
- Dimensions
- unknown
- Extent
- 1 online resource (xviii, 132 pages)
- File format
- unknown
- Form of item
- online
- Isbn
- 9786612083556
- Level of compression
- unknown
- Media category
- computer
- Media MARC source
- rdamedia
- Media type code
-
- c
- Quality assurance targets
- unknown
- Reformatting quality
- unknown
- Sound
- unknown sound
- Specific material designation
- remote
- System control number
- (OCoLC)311565225
Subject
- United States
- Drugs -- Design
- Drugs -- United States -- Design
- Electronic book
- Electronic books
- MEDICAL -- Allied Health Services | General
- Models, Economic
- Orphan Drug Production -- economics
- Orphan Drug Production -- trends
- Orphan drugs -- Government policy
- Orphan drugs -- Government policy -- United States
- Pharmaceutical policy
- Pharmaceutical policy -- United States
- Research -- economics
- Research -- trends
- United States
Genre
Member of
Library Links
Embed
Settings
Select options that apply then copy and paste the RDF/HTML data fragment to include in your application
Embed this data in a secure (HTTPS) page:
Layout options:
Include data citation:
<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.library.mst.edu/portal/Breakthrough-business-models--drug-development/VLWJQFqWmJ8/" typeof="Book http://bibfra.me/vocab/lite/Item"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.library.mst.edu/portal/Breakthrough-business-models--drug-development/VLWJQFqWmJ8/">Breakthrough business models : drug development for rare and neglected diseases and individualized therapies: workshop summary, [edited by] Theresa Wizeman, Sally Robinson, and Robert Giffin ; Forum on Drug Discovery, Development, and Translation, Board on Health Services Policy, Institute of Medicine of the National Academies</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.library.mst.edu/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.library.mst.edu/">Missouri University of Science & Technology Library</a></span></span></span></span></div>
Note: Adjust the width and height settings defined in the RDF/HTML code fragment to best match your requirements
Preview
Cite Data - Experimental
Data Citation of the Item Breakthrough business models : drug development for rare and neglected diseases and individualized therapies: workshop summary, [edited by] Theresa Wizeman, Sally Robinson, and Robert Giffin ; Forum on Drug Discovery, Development, and Translation, Board on Health Services Policy, Institute of Medicine of the National Academies
Copy and paste the following RDF/HTML data fragment to cite this resource
<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.library.mst.edu/portal/Breakthrough-business-models--drug-development/VLWJQFqWmJ8/" typeof="Book http://bibfra.me/vocab/lite/Item"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.library.mst.edu/portal/Breakthrough-business-models--drug-development/VLWJQFqWmJ8/">Breakthrough business models : drug development for rare and neglected diseases and individualized therapies: workshop summary, [edited by] Theresa Wizeman, Sally Robinson, and Robert Giffin ; Forum on Drug Discovery, Development, and Translation, Board on Health Services Policy, Institute of Medicine of the National Academies</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.library.mst.edu/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.library.mst.edu/">Missouri University of Science & Technology Library</a></span></span></span></span></div>
